Pharmaceuticals

Cyclosporine Drugs Market Size Forecast: Revenue and CAGR by 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Cyclosporine Drugs Industry By The Forecast Year 2029?

The cyclosporine drugs market has experienced robust growth in recent times. This market is projected to expand from $1.64 billion in 2024 to reach $1.73 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 5.6%. Factors contributing to this historical expansion include an escalating geriatric population, the expanding application of cyclosporine in ophthalmic treatments, a rise in clinical trials involving cyclosporine-based medications, enhanced government backing for pharmaceutical research and development, and a notable increase in healthcare expenditures.

The cyclosporine drugs market is projected to experience substantial expansion over the upcoming years. It is set to reach $2.18 billion by 2029, achieving a compound annual growth rate (CAGR) of 6.0%. This growth during the forecast period is fueled by factors such as the rising incidence of autoimmune diseases, an increase in organ transplant procedures, a growing population of patients with dry eye disease, heightened awareness of cyclosporine-based treatments, and a developing healthcare infrastructure. Key trends anticipated in the forecast period encompass progress in drug delivery mechanisms, enhanced formulations for cyclosporine medications, novel non-preserved eye drop formulations, the emergence of generic cyclosporine drugs, and the increasing use of cyclosporine in veterinary applications.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24198&type=smp

Which Drivers Are Impacting The Cyclosporine Drugs Market?

The rising demand for organ transplantation is expected to drive the expansion of the cyclosporine drugs market in the future. Organ transplantation involves a medical process where a non-functioning or compromised organ within an individual’s body is exchanged for a healthy one obtained from another donor. The increase in organ transplantation can be attributed to the growing incidence of end-stage organ conditions, coupled with medical diagnostic and treatment improvements that have prolonged patient lives, resulting in more people needing organ replacement. Cyclosporine drugs are essential in organ transplantation because they inhibit the immune system’s inherent tendency to reject foreign tissues, thus assisting in safeguarding the transplanted organ from assault and harm by the recipient’s immune cells. As an illustration, the Australian Institute of Health and Welfare, an Australia-based government entity, reported in December 2024 that 938 kidney transplant procedures were conducted in Australia during 2022, with 90% representing initial kidney transplants. Of the kidneys transplanted, 713, or 76%, originated from deceased donors, whereas 225, or 24%, were sourced from living donors. Consequently, the growing need for organ transplantation is fueling the expansion of the cyclosporine drugs market.

What Are The Emerging Segments Gaining Attention In The Cyclosporine Drugs Market?

The cyclosporine drugs market covered in this report is segmented –

1) By Type: Oral, Parenteral

2) By Drug Formulation: Capsules, Oral Solutions, Injectable Forms, Topical Preparations

3) By Application: Organ Transplantation, Autoimmune Disorders, Ophthalmic Disorders, Dermatological Disorders

4) By End-User: Hospitals, Specialty Clinics, Homecare Settings, Pharmaceutical Retail

Subsegments:

1) By Oral: Capsules, Tablets, Oral Solution

2) By Parenteral: Intravenous Injection, Intravenous Infusion

How Are Emerging Market Trends Shaping The Cyclosporine Drugs Industry Landscape?

Major companies within the cyclosporine drugs market are focusing on developing advanced solutions, such as ophthalmic medications, to deliver targeted treatment directly to the eyes. Ophthalmic medications are pharmaceutical products specifically formulated for addressing eye conditions, including infections, inflammation, and dry eye, often provided as drops, ointments, or gels. For instance, in June 2023, Novaliq GmbH, a Germany-based biopharmaceutical company, announced the U.S. Food and Drug Administration (FDA) approval for VEVYE, which is the first water-free and preservative-free 0.1% cyclosporine ophthalmic solution. VEVYE, developed using Novaliq’s proprietary EyeSol technology, presents an innovative solution for treating dry eye disease, demonstrating significant effectiveness within four weeks. Its unique water-free formulation enhances drug stability and improves patient comfort while minimizing irritation. This approval represents a significant advancement in ophthalmic drug delivery, allowing for more precise targeting of inflammation.

Who Are The Major Companies Operating In The Cyclosporine Drugs Market?

Major companies operating in the cyclosporine drugs market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Limited, Astellas Pharma Inc., Apotex Inc., Dr. Reddy’s Laboratories Limited, Cipla Limited, Hikma Pharmaceuticals PLC, Santen Pharmaceutical Co. Ltd., Biocon Limited, Glenmark Pharmaceuticals Limited, Alkem Laboratories Limited, Concord Biotech Limited, CKD Bio Corporation, ChemWerth Inc., Strides Pharma Science Limited, Fishfa Biogenics.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/cyclosporine-drugs-global-market-report

Which Regional Markets Are Contributing Most To The Cyclosporine Drugs Industry Expansion?

North America was the largest region in the cyclosporine drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cyclosporine drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Cyclosporine Drugs Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24198&type=smp

Browse Through More Reports Similar to the Global Cyclosporine Drugs Market 2025, By The Business Research Company

Anti Hypertensive Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anti-hypertensive-drugs-global-market-report

Antithrombotic Drugs Market 2025

https://www.thebusinessresearchcompany.com/report/antithrombotic-drugs-market

Acne Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/acne-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795